BROLUCIZUMAB vs BROMFENAC: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BROLUCIZUMAB vs BROMFENAC: Safety Overview
| Metric | BROLUCIZUMAB | BROMFENAC |
|---|---|---|
| Total FAERS Reports | 682 | 1,185 |
| Deaths Reported | 41 | 1 |
| Death Rate | 6.0% | 0.1% |
| Hospitalizations | 105 | 35 |
| Average Patient Age | 69.5 yrs | 70.5 yrs |
| % Female Patients | 57.1% | 66.2% |
| FDA Approval Date | N/A | Apr 5, 2013 |
| Manufacturer | Novartis Pharmaceuticals Corporation | Alembic Pharmaceuticals Limited |
| Route | INTRAVITREAL | OPHTHALMIC |
| Marketing Status | N/A | Discontinued |